3rd Quarter - Report

BROWN RUDNICK LLP for HOSPIRA, INC.

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 1548 - The Pathway to Biosimilars Act; S. 726 & H.R. 1427 - The Promoting Innovation and Access to Life-Savings Medicine Act; S.301 - Physician Payments Sunshine Act of 2009; Issues relating to drug pedigree; H.R. 1346 & S. 540 - Medical Device Safety Act of 2009; The Affordable Health Choices Act; America's Healthy Future Act of 2009 relating to biosimilars

LobbyistCovered position, as disclosed
LISA LAYMAN SPA, Sen Stabenow(05-07)
HENRY W MENN Min SD & Counsel, Cmte on Vet Affairs (04)

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1346 (111th), S. 726 (111th), H.R. 1427 (111th), S. 301 (111th), S. 540 (111th), H.R. 1548 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.